Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
23andme
boston blog main
boston top stories
life sciences
national blog main
national top stories
tc
bio
blueprint medicines
cancer
clinical trials
drugs
health
indiana blog main
indiana top stories
new york blog main
new york top stories
roche
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
akcea therapeutics
anylam pharmaceuticals
apple watch
archive
avapritinib
biohacking
biology
biotech
boston
boulder/denver blog main
boulder/denver top stories
cancer drugs
capmatinib
cardiomyopathy
column
companion diagnostic
detroit blog main
What
fda
10
×
genetic
10
×
drug
disease
andme
approval
medical
cancer
company
data
dna
health
rare
tell
administration
andme’s
approved
approves
consumer
designed
direct
diseases
doctor’s
food
future
genes
including
late
medicine
medicines
oks
onset
pfizer
read
reports
risk
targeting
technology
test
tests
Language
unset
Current search:
genetic
×
fda
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@slashgear.com
4 years ago
FDA approves $2.1m gene therapy for infants with rare genetic disease
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@techcrunch.com
7 years ago
23andMe is finally allowed to tell you if you have the genes for Parkinsons
@theverge.com
7 years ago
No doctor required: 23andMe cleared by FDA for at-home DNA tests
@techcrunch.com
8 years ago
The Evolution Of The Biohacking Ecosystem
@theverge.com
8 years ago
Ancestry.com is talking to the FDA about using DNA to estimate people's risk of disease
@techcrunch.com
9 years ago
We Asked Rock Health Founder Halle Tecco About The Future Of Digital Medicine
@theverge.com
9 years ago
23andMe to offer users' medical data to Pfizer for research